Measurement of the Proteinase Inhibitors of the Bovine Pancreas by Radioimmunoassay

Bovine pancreas contains two polypeptide trypsin inhibitors that are not homologous and differ in their inhibitory activity towards chymotrypsin, kallikrein, elastase, and other serine proteinases. The Kunitz inhibitor and the Kazal inhibitor are present in approximately equimolar concentrations in bovine pancreatic tissue, yet only the Kazal inhibitor is detectable in the pancreatic juice. The Kazal inhibitor has been named the pancreatic secretory trypsin inhibitor, PSTI because its concentration in the pancreatic juice parallels that of the exocrine secretory proteins. The Kunitz inhibitor is considered the intracellular inhibitor, however, no direct information is available concerning the intracellular localization of these inhibitors in the pancreas. The preparation of /sup 125/I-labeled derivatives of Kazal and Kunitz inhibitors by the lactoperoxidase method and a radioimmunoassay for each inhibitor are described

A 1-acetamido derivative of 6-epi-valienamine: an inhibitor of a diverse group of β-N-acetylglucosaminidases

The synthesis of an analogue of 6-epi-valienamine bearing an acetamido group and its characterisation as an inhibitor of β-N-acetylglucosaminidases are described. The compound is a good inhibitor of both human O-GlcNAcase and human β-hexosaminidase, as well as two bacterial β-N-acetylglucosaminidases. A 3-D structure of the complex of Bacteroides thetaiotaomicron BtGH84 with the inhibitor shows the unsaturated ring is surprisingly distorted away from its favoured solution phase conformation and reveals potential for improved inhibitor potency

Geysering inhibitor pipe

Smaller concentric pipe is welded to main pipe beginning above bottom of isolation valve and terminating in storage tank at top. There is continuous circulation of fluid which maintains fluid temperature below boiling temperature of liquid oxygen

AKT activation controls cell survival in response to HDAC6 inhibition.

HDAC6 is emerging as an important therapeutic target for cancer. We investigated mechanisms responsible for survival of tumor cells treated with a HDAC6 inhibitor. Expression of the 20 000 genes examined did not change following HDAC6 treatment in vivo. We found that HDAC6 inhibition led to an increase of AKT activation (P-AKT) in vitro, and genetic knockdown of HDAC6 phenocopied drug-induced AKT activation. The activation of AKT was not observed in PTEN null cells; otherwise, PTEN/PIK3CA expression per se did not predict HDAC6 inhibitor sensitivity. Interestingly, HDAC6 inhibitor treatment led to inactivating phosphorylation of PTEN (P-PTEN Ser380), which likely led to the increased P-AKT in cells that express PTEN. Synergy was observed with phosphatidylinositol 3-kinases (PI3K) inhibitor treatment in vitro, accompanied by increased caspase 3/7 activity. Furthermore, combination of HDAC6 inhibitor with a PI3K inhibitor caused substantial tumor growth inhibition in vivo compared with either treatment alone, also detectable by Ki-67 immunostaining and (18)F-FLT positron emission tomography (PET). In aggregate AKT activation appears to be a key survival mechanism for HDAC6 inhibitor treatment. Our findings indicate that dual inhibition of HDAC6 and P-AKT may be necessary to substantially inhibit growth of solid tumors

Inhibition effect of potassium dichromate on the corrosion protection of mild steel reinforcement in concrete

The inhibition of potassium dichromate on the corrosion protection of mild steel embedded in concrete and partially immersed in sulphuric acid and sodium chloride environments was evaluated at ambient temperatures. The experiments were performed using electrochemical potential monitoring method. Varying quantities of the inhibitor was used. In the NaCl test medium, the effectiveness of the inhibitor improved as higher concentration was used. The best inhibition was achieved in the reinforced concrete sample admixed with 9 g potassium dichromate. Steel-reinforced concrete sample admixed with 3 and 9 g potassium dichromate inhibitor had the highest improvement in compressive strength. The potassium dichromate inhibitor was most effective amongst other inhibitor concentrations used when 7.5 g was admixed with the sample in the H2SO4 medium. The sulphuric acid medium had a deleterious effect on the strength of concrete test specimens

Freeze the BCI until the user is ready: a pilot study of a BCI inhibitor

In this paper we introduce the concept of Brain-Computer Interface (BCI) inhibitor, which is meant to standby the BCI until the user is ready, in order to improve the overall performance and usability of the system. BCI inhibitor can be defined as a system that monitors user's state and inhibits BCI interaction until specific requirements (e.g. brain activity pattern, user attention level) are met. In this pilot study, a hybrid BCI is designed and composed of a classic synchronous BCI system based on motor imagery and a BCI inhibitor. The BCI inhibitor initiates the control period of the BCI when requirements in terms of brain activity are reached (i.e. stability in the beta band). Preliminary results with four participants suggest that BCI inhibitor system can improve BCI performance.Comment: 5th International Brain-Computer Interface Workshop (2011

Spontaneous bleeding in a patient with malignant lymphoma: A case of acquired hemophilia

Background: Acquired hemophilia is a rare condition which can be associated with lymphoproliferative disease. Case Report: Eleven yea rs after the diagnosis of immunocytoma had been made, a 72-year-old man developed a high-titer factor VIII inhibitor. At this time, the lymphoma was without significant progress and there was no paraprotein in the serum. Partial thromboplastin time (PTT) was 83 a, factor-VIII clotting activity was <1%, and inhibitor level was 50.4 Bethesda units. The patient presented with spontaneous hematomas in the skin and musculature of the extremities. Following combination chemotherapy with cyclophosphamide, vincristine and prednisolone (COP), there was a prompt disappearance of the inhibitor and normalization of coagulation; however, the patient developed serious infectious complications. When the inhibitor recurred he was treated with low-dose cyclophosphamide and prednisolone. This time there was a more delayed response, but the inhibitor disappeared again completely. Two months after cessation of therapy, there was again relapse. Conclusion: Causal relationship between lymphoma and acquired hemophilia remains speculative. At least in some cases of factor VIII inhibitors associated with malignant disease, immunosuppressive therapy may be sufficient to suppress the inhibitor

Inhibition Effect of N, N'-Dimethylaminoethanol on the Corrosion of Austenitic Stainless Steel Type 304

The effect of N,N'-dimethylaminoethanol on the corrosion of austenitic stainless steel type 304 in 3M H2SO4 has been studied by weight-loss method and linear polarization measurement in different concentrations of the compound. The inhibition efficiencies of the inhibitor compound on the corrosion of the stainless steel were evaluated through assessment of the anodic and cathodic polarization curves of the alloy, the spontaneity of the electrochemical process, inhibition mechanism and adsorption isotherm. The inhibitor efficiency increased with increase in the inhibitor concentration. Results obtained reveal that the inhibitor performed effectively on the stainless steel providing good protection against pitting and uniform corrosion in the chloride containing acidic solutions. The compound act through physiochemical mechanism on the stainless steel surface and obeyed Langmuir adsorption isotherm. The values of the inhibition efficiency calculated from the two techniques are in reasonably good agreement. Polarization studies showed that the compounds behave as mixed type inhibitor in the aggressive media